TWI348370B - Piperidinyl prostaglandin e analogs - Google Patents

Piperidinyl prostaglandin e analogs

Info

Publication number
TWI348370B
TWI348370B TW094100542A TW94100542A TWI348370B TW I348370 B TWI348370 B TW I348370B TW 094100542 A TW094100542 A TW 094100542A TW 94100542 A TW94100542 A TW 94100542A TW I348370 B TWI348370 B TW I348370B
Authority
TW
Taiwan
Prior art keywords
analogs
prostaglandin
piperidinyl
piperidinyl prostaglandin
Prior art date
Application number
TW094100542A
Other languages
English (en)
Chinese (zh)
Other versions
TW200533350A (en
Inventor
David W Old
Danny T Dinh
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of TW200533350A publication Critical patent/TW200533350A/zh
Application granted granted Critical
Publication of TWI348370B publication Critical patent/TWI348370B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C07D211/76—Oxygen atoms attached in position 2 or 6

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
TW094100542A 2004-01-22 2005-01-07 Piperidinyl prostaglandin e analogs TWI348370B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/763,702 US6977260B2 (en) 2004-01-22 2004-01-22 Piperidinyl prostaglandin E analogs

Publications (2)

Publication Number Publication Date
TW200533350A TW200533350A (en) 2005-10-16
TWI348370B true TWI348370B (en) 2011-09-11

Family

ID=34795110

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094100542A TWI348370B (en) 2004-01-22 2005-01-07 Piperidinyl prostaglandin e analogs

Country Status (11)

Country Link
US (1) US6977260B2 (enExample)
EP (1) EP1722795B1 (enExample)
JP (1) JP4740883B2 (enExample)
AR (1) AR047436A1 (enExample)
AT (1) ATE394101T1 (enExample)
AU (1) AU2005209209B2 (enExample)
CA (1) CA2553387C (enExample)
DE (1) DE602005006534D1 (enExample)
ES (1) ES2303672T3 (enExample)
TW (1) TWI348370B (enExample)
WO (1) WO2005072735A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7326716B2 (en) * 2003-06-06 2008-02-05 Allergan, Inc. Treatment of inflammatory bowel disease
WO2006047466A2 (en) * 2004-10-21 2006-05-04 Duke University Ophthamological drugs
US20070254920A1 (en) * 2006-04-26 2007-11-01 Aerie Pharmaceuticals, Inc. Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3220156C2 (de) * 1982-05-28 1990-01-25 Heida Houston Tex. Thurlow Mit Metallgriffen, insbesondere Edelstahlgriffen, versehenes Koch- und Bratgeschirr mit Deckel
IT1225716B (it) * 1988-10-26 1990-11-22 Esacontrol Spa Dispositivo per la protezione dei rele' di binario dai disturbi elettrici
CA2021316C (en) 1989-07-27 2000-10-24 Ming Fai Chan Intraocular pressure reducing 11-acyl prostaglandins
US5034413A (en) 1989-07-27 1991-07-23 Allergan, Inc. Intraocular pressure reducing 9,11-diacyl prostaglandins
US4994274A (en) 1989-07-27 1991-02-19 Allergan, Inc. Intraocular pressure reducing 11,15-diacyl prostaglandins and method of using
US5028624A (en) 1989-07-27 1991-07-02 Allergan, Inc. Intraocular pressure reducing 9,15-diacyl prostaglandins
DE4318713C1 (de) * 1993-06-07 1994-09-15 Daimler Benz Ag Zahnräderwechselgetriebe der Vorgelegebauart
JP4766875B2 (ja) * 2002-06-06 2011-09-07 メルク フロスト カナダ リミテツド Ｅｐ４受容体作動薬、組成物及びその方法
US7053085B2 (en) 2003-03-26 2006-05-30 Merck & Co. Inc. EP4 receptor agonist, compositions and methods thereof
WO2004063158A1 (en) 2003-01-10 2004-07-29 F.Hoffmann-La Roche Ag 2-piperidone derivatives as prostaglandin agonists
US6747037B1 (en) * 2003-06-06 2004-06-08 Allergan, Inc. Piperidinyl prostaglandin E analogs
WO2004108215A1 (en) * 2003-06-06 2004-12-16 Allergan, Inc. Piperidinyl prostaglandin e analogs

Also Published As

Publication number Publication date
ATE394101T1 (de) 2008-05-15
HK1099203A1 (en) 2007-08-10
AU2005209209B2 (en) 2012-03-08
ES2303672T3 (es) 2008-08-16
EP1722795A1 (en) 2006-11-22
AU2005209209A1 (en) 2005-08-11
WO2005072735A1 (en) 2005-08-11
US6977260B2 (en) 2005-12-20
CA2553387A1 (en) 2005-08-11
TW200533350A (en) 2005-10-16
EP1722795B1 (en) 2008-05-07
AR047436A1 (es) 2006-01-18
US20050164990A1 (en) 2005-07-28
JP2007520489A (ja) 2007-07-26
JP4740883B2 (ja) 2011-08-03
DE602005006534D1 (de) 2008-06-19
CA2553387C (en) 2013-04-02

Similar Documents

Publication Publication Date Title
ZA200700357B (en) Tetrapetide analogs
AP2006003638A0 (en) Prostaglandin nitrooxyderivatives
IL209859A0 (en) Epitope analogs
IL183360A0 (en) 12-aryl prostaglandin analogs
IL182316A0 (en) N-benzenesulfonyl substituted anilino-pyrimidine analogs
IL181857A0 (en) Quinolone analogs
EP1718638A4 (en) NEW COMPOUNDS
GB0417401D0 (en) Stabilised prostaglandin composition
EP1610759A4 (en) SUBSTITUTED QUINOBENZOXAZINE ANALOGUES
GB0402496D0 (en) Novel compounds
EP1805132A4 (en) NEW COMPOUNDS
GB0427403D0 (en) Novel compounds I
EP1796793A4 (en) NEW CONNECTIONS
EP1810029A4 (en) Topiramate analogs
TWI348370B (en) Piperidinyl prostaglandin e analogs
GB0422755D0 (en) Novel compounds
GB0422765D0 (en) Novel compounds
GB0407519D0 (en) Novel compounds
GB0418034D0 (en) Novel compounds
GB0418268D0 (en) Novel compounds
GB0420261D0 (en) Novel compounds
GB0420278D0 (en) Novel compounds
GB0420280D0 (en) Novel compounds
GB0420282D0 (en) Novel compounds
GB0420317D0 (en) Novel compounds

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees